Treatment of hereditary angioneurotic oedema (HANE) with tibolone.

Ott, H W; Mattle, V; Hadziomerovic, D; Licht, P; Döinghaus, K; Rubbert, A; Manger, K; Manger, B; Kalden, J; Wildt, L

Ott, H W; Mattle, V; Hadziomerovic, D; Licht, P; Döinghaus, K; Rubbert, A; Manger, K; Manger, B; Kalden, J; Wildt, L.

Affiliation

Ott HW; Clinical Division of Gynaecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Austria. helmut.ott@uibk.ac.at

Clin Endocrinol (Oxf) ; 66(2): 180-4, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17223985

Subject(s)

Angioedema/drug therapy; Angioedema/genetics; Norpregnenes/therapeutic use; Adult; Complement C1 Inactivator Proteins/therapeutic use; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Pilot Projects; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angioedema / Norpregnenes Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2007 Document type: Article Affiliation country: Austria Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links